Ionis to present at 41st Annual J.P. Morgan Healthcare conference

Rhea-AI Summary

Ionis Pharmaceuticals, based in Carlsbad, California, announced that Brett P. Monia, Ph.D., will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 9:45 a.m. PT (12:45 p.m. ET). The presentation will include a company overview followed by a Q&A session. A live webcast will be available on the Ionis website, with a replay accessible within 48 hours. Ionis has over 30 years of experience in RNA-targeted therapy and currently offers three marketed medicines alongside a robust late-stage pipeline.

CARLSBAD, Calif., Jan. 4, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview and participate in a Q&A session at the 41^st Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT (12:45 p.m. ET) on Wednesday, January 11, 2023.

A live webcast of the presentation and Q&A session will be available on the Investors & Media section of the Ionis website. The replay will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals, Inc.

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-41st-annual-jp-morgan-healthcare-conference-301712823.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When will Ionis Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Ionis Pharmaceuticals will present at the J.P. Morgan Healthcare Conference on January 11, 2023, at 9:45 a.m. PT.

Who is presenting for Ionis Pharmaceuticals at the conference?

Brett P. Monia, Ph.D., the CEO of Ionis Pharmaceuticals, will present at the conference.

Is there a way to watch Ionis Pharmaceuticals' presentation live?

Yes, a live webcast of the presentation will be available on the Investors & Media section of the Ionis website.

Will the Ionis Pharmaceuticals presentation be available after the live event?

Yes, a replay of the presentation will be available within 48 hours and archived for a limited time.

What is the focus of Ionis Pharmaceuticals in the healthcare market?

Ionis Pharmaceuticals focuses on RNA-targeted therapy and has a late-stage pipeline in cardiovascular and neurological franchises.